Merel Ritskes-Hoitinga (SYRCLE, Department for Health Evidence) has been appointed honorary Skou Professor at the Department of Clinical Medicine, at Aarhus University, Denmark.
The official inauguration of 47 Honorary Skou Professors was held 8 October 2019 in Aarhus https://health.au.dk/en/research/honorary-skou-professors/.
The aim is to introduce new perspectives to teaching, strengthen relations with leading research units abroad and establish joint research projects and funding applications. The Skou Professors will participate in the academic work of the individual departments, e.g. as guest lecturers and co-supervisors on PhD projects, in the form of research partnerships and joint funding applications or as guest lecturers at conferences. In order to connect the Skou professors to their respective departments in the best way, each of them has been affiliated to a ‘champion’. For Prof. Merel Ritskes-Hoitinga this is Prof. Dr. Gregers Wegener at the Department of Clinical Medicine at the Translational Neuropsychiatry Unit.Together with Dr. Birgitte Kousholt, Prof. Wegener has founded AUGUST https://august.au.dk/. Merel Ritskes-Hoitinga, Gregers Wegener and Birgitte Kousholt have already been working closely together for a number of years in setting up teaching and research in the field of preclinical systematic reviews, and the official appointment as honorary Skou professor will stimulate and broaden this work further. Merel Ritskes-Hoitinga held her inaugural lecture on 9 October 2019, with the title “The benefits of preclinical systematic reviews”.
Merel Ritskes - Hoitinga is member of theme Reconstructive and regenerative medicine.
Related news items
650,000 Euro funding for research into the phasing out of medication for leukaemia patients30 July 2020
With a 650,000 euro funding from ZonMw, researchers from the Haematology and Pharmacy departments can develop a medication phasing out strategy for patients with chronic myeloid leukaemia. This strategy will be tested in practice.read more
Increased role of patients after bowel cancer treatment30 July 2020
Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer.read more
ERC Proof of Concept grant received by Ronald van Rij30 July 2020
Ronald van Rij, theme Infectious diseases and global health, received an ERC (European Research Council) Proof of Concept grant of 150,000 euros, in order to make arbovirus vaccines even safer.read more
Hypatia fellowship Call is open30 July 2020
The Hypatia fellowship round with the deadline 31 May has been canceled. Therefore, the next available deadline will be 27 September 2020. Radboudumc researchers are invited to scout young potentials to fill the strategic gaps within the research themes imbedded in RIHS and RIMLS.read more
Mihai Netea and colleagues published two papers back-to-back in The Journal of Clinical Investigation.29 July 2020
These back-to-back articles investigated the effect of BCG vaccination on trained immunity. The first article shows that BCG vaccination inhibits systemic inflammation, depending on gender. The second article demonstrates that the circadian rhythm influences the induction of trained immunity.read more
Genetic mutation reveals how coronavirus strikes TLR7 plays essential role in disease process28 July 2020
''Does a congenital immune defect play an important role in the defense against Coronavirus?'' This was published by Cas van der Made, Frank van der Veerdonk and Alexander Hoischen.read more